Plasma miRNAs as biomarkers for endometriosis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Can plasma miRNAs be used for the non-invasive diagnosis of endometriosis in infertile women? SUMMARY ANSWER: miRNA-based diagnostic models for endometriosis failed the test of independent validation. WHAT IS KNOWN ALREADY: Circulating miRNAs have been described to be differentially expressed in patients with endometriosis compared with women without endometriosis, suggesting that they could be used for the non-invasive diagnosis of endometriosis. However, these studies have shown limited consistency or conflicting results, and no miRNA-based diagnostic test has been validated in an independent patient cohort. STUDY DESIGN, SIZE, DURATION: We performed genome-wide miRNA expression profiling by small RNA sequencing to identify a set of plasma miRNAs with discriminative potential between patients with and without endometriosis. Expression of this set of miRNAs was confirmed by RT-qPCR. Diagnostic models were built using multivariate logistic regression with stepwise feature selection. In a final step, the models were tested for validation in an independent patient cohort. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Plasma of all patients was available in the biobank of the Leuven Endometriosis Centre of Excellence. Biomarker discovery and model development were performed in a discovery cohort of 120 patients (controls = 38, endometriosis = 82), and models were tested for validation in an independent cohort of 90 patients (controls = 30, endometriosis = 60). RNA was extracted with the miRNeasy Plasma Kit. Genome-wide miRNA expression analysis was done by small RNA sequencing using the NEBNext small RNA library prep kit and the NextSeq 500 System. cDNA synthesis and qPCR were performed using the Qiagen miScript technology. MAIN RESULTS AND THE ROLE OF CHANCE: We identified a set of 42 miRNAs with discriminative power between patients with and without endometriosis based on genome-wide miRNA expression profiling. Expression of 41 miRNAs was confirmed by RT-qPCR, and 3 diagnostic models were built. Only the model for minimal–mild endometriosis (Model 2: hsa-miR-125b-5p, hsa-miR-28-5p and hsa-miR-29a-3p) had diagnostic power above chance performance in the independent validation (AUC = 60%) with an acceptable sensitivity (78%) but poor specificity (37%). LIMITATIONS, REASONS FOR CAUTION: The diagnostic models were built and tested for validation in two patient cohorts from a single tertiary endometriosis centre. Further validation tests in large cohorts with patients from multiple endometriosis centres are needed. WIDER IMPLICATION OF THE FINDINGS: Our study supports a possible biological link between certain miRNAs and endometriosis, but the potential of these miRNAs as clinically useful biomarkers is questionable in women with infertility. Large studies in well-described patient cohorts, with rigorous methodology for miRNA expression analysis, sufficient statistical power and an independent validation step, are necessary to answer the question of whether miRNAs can be used as diagnostics markers for endometriosis. STUDY FUNDING/COMPETING INTEREST(S): The project was funded by a grant from the Research Foundation - Flanders (FWO). A.V., D.F.O. and D.P. are PhD fellows from the FWO. T.D. is vice president and Head of Global Medical Affairs Fertility, Research and Development, Merck KGaA, Darmstadt, Germany. He is also a professor in Reproductive Medicine and Biology at the Department of Development and Regeneration, Group Biomedical Sciences, KU Leuven (University of Leuven), Belgium and an adjunct professor at the Department of Obstetrics and Gynecology in the University of Yale, New Haven, USA. Neither his corporate role nor his academic roles represent a conflict of interest with respect to the work done by him for this study. The other co-authors have no conflict of interest. Trial registration number: Not applicable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., & Vandesompele, J. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r19 · Cited by 4,023
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211 · cited 2×
“Hence, the gold standard for diagnosis is still laparoscopic visualization of lesions confirmed by histology (Dunselman et al. , 2014).”
Self-citationGiudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924 · cited 1×
“Endometriosis, defined as the presence of endometrial-like tissue outside the uterus, is a chronic gynaecological disease with an overall prevalence of 2–10% in women of reproductive age and up to 50% in infertile women (Giudice, 2010).”
Simoens, S., Dunselman, G., Dirksen, C., Hummelshoj, L., Bokor, A., Brandes, I., Brodszky, V., Canis, M., Colombo, G. L., DeLeire, T., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des073 · Cited by 1,070 · cited 1×
“Due to its chronic character, lack of medical treatment and debilitating symptoms, endometriosis results in major public health care costs, comparable to that of Crohn’s disease (Simoens et al. , 2012).”
Self-citationImaging modalities for the non-invasive diagnosis of endometriosis
Nisenblat, V., Bossuyt, P. M., Farquhar, C., Johnson, N., & Hull, M. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009591.pub2 · Cited by 538 · cited 1×
“Ultrasound can detect ovarian endometriotic cysts and deep endometriotic nodules but does not rule out peritoneal endometriosis or endometriosis-associated adhesions (Nisenblat et al. , 2016).”
Peripheral biomarkers of endometriosis: a systematic review
May, K. E., Conduit-Hulbert, S. A., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq009 · Cited by 418 · cited 1×
“…an aid to diagnosis, a biomarker for endometriosis needs to distinguish women with endometriosis from unaffected women with a similar presentation (May et al. , 2010), In our study, both cases and controls indeed had a similar clinical presentation and indication for surgery (nearly all had…”
The role of microRNAs in endometriosis and associated reproductive conditions
Ohlsson Teague, E. M. C., Print, C. G., & Hull, M. L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp034 · Cited by 309
Shah, J. S., Soon, P. S., & Marsh, D. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153200 · Cited by 216 · cited 2×
“Using the miR-Ratio thresholds of 5 and 7 for assessment of hemolysis in our discovery cohort, we found 39 samples had a low risk of hemolysis (miR-Ratio < 5), 31 samples had an intermediate risk (5 < miR-Ratio < 7) and 50 samples had a high risk of hemolysis (miR-ratio > 7) (Shah et al. , 2016).”
Update on biomarkers for the detection of endometriosis
Fassbender, A., Burney, R. O., F. O, D., D’Hooghe, T., & Giudice, L. (2015) · BioMed Research International · doi:10.1155/2015/130854 · Cited by 195 · cited 1×
“Since a diagnostic laparoscopy is often considered in these patients, they represent a relevant patient group for which a non-invasive diagnostic test for endometriosis would be useful (Vodolazkaia et al. , 2012, Fassbender et al. , 2015).”
Self-citation
Cited by
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“…in endometrial tissue, blood, menstrual or uterine fluids to diagnose endometriosis (Mol et al. , 1998; May et al. , 2010; May et al. , 2011; Liu et al. , 2015; Cosar et al. , 2016; Gupta et al. , 2016; Hirsch et al. , 2016; Nisenblat et al. , 2016a; Vanhie et al. , 2019; Moustafa et al. , 2020).”
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
MicroRNome analysis generates a blood-based signature for endometriosis
Bendifallah, S., Dabi, Y., Suisse, S., Jornea, L., Bouteiller, D., Touboul, C., Puchar, A., & Daraï, E. (2022) · Scientific Reports · doi:10.1038/s41598-022-07771-7 · Cited by 61
An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review
Brulport, A., Bourdon, M., Vaiman, D., Drouet, C., Pocate-Cheriet, K., Bouzid, K., Marcellin, L., Santulli, P., Abo, C., Jeljeli, M., et al. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01181-8 · Cited by 52
Zafari, N., Tarafdari, A. M., Izadi, P., Noruzinia, M., Yekaninejad, M. S., Bahramy, A., & Mohebalian, A. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00415-z · Cited by 36
Metadata
- Authors
- Vanhie, A., O, D., Peterse, D., Beckers, A., Cuéllar, A., Fassbender, A., Meuleman, C., Mestdagh, P., & D’Hooghe, T.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-08-14
- Volume
- 34
- Issue
- 9
- Pages
- 1650-1660
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2968520120
- Cited by
- 122
- References
- 17
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.